Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
15/05/2025
Truist Securities: Maintains rating on Allogene Therapeutics (ALLO.US) from Buy to Buy rating, with target price adjusted from $14.00 to $10.00.
Latest
3 m ago
Apple is reportedly planning to add eye scrolling functionality to the Vision Pro headset.
3 m ago
The Hang Seng Index main contract night session closed up 0.16% at 23,554 points.
4 m ago
Federal Aviation Administration: Thunderstorms cause flight delays at New York Metropolitan Airport.
5 m ago
International oil prices fell on the 14th.
6 m ago
The dollar index rose on the 14th.
See all latest